Last October saw the first meeting of the Medicine, Markets and Morals Network. Today and yesterday I attended their third and final (for now) meeting in London. The network brings together researchers from across the social… Read More »Conference round-up: Medicine, Markets and Morals Network Meeting Three
accountability for reasonableness
NICE recently completed their appraisal of the hepatitis C drug sofosbuvir. However, as has been reported in the media, NHS England will not be complying with the guidance within the normal time period. The cost of a 24 week… Read More »Sofosbuvir: a fork in the road for NICE?